Can we see some ID, please?

You must be of legal age in your province of residence to enter our website.

Untitled | Lift & Co. Cannabis Expo

Jan 11

08:00am - 09:00am

Registration & Breakfast

09:00am - 09:10am

Welcome Remarks

Welcome from LCBC Chair and Lift & Co. Board Member Deborah Rosati
Cannabis is poised to become one of the most influential consumer packaged goods industries in the world, and Canadian companies have a unique opportunity to build globally powerful brands. In a highly restricted marketing environment, data intelligence is paramount to understanding the customer and develop successful go-to-market strategies, as well as to build a passionate, knowledgeable and loyal consumer base. Lift & Co. and Headset take the stage to share combined insights into cannabis purchase and demographic analytics, discuss if Canada will follow U.S. trends and to provide an outlook on the future of the Canadian market.
As the United States inches towards an eventual lifting of its federal prohibition on cannabis, Canadian operators recognize the importance of penetrating the world’s largest economy. Cannabis’ continued Schedule I status and the U.S.’s notoriously competitive business philosophy make this a challenge: despite these factors, federally legal hemp offers one entry avenue, as do creative deals premised by conditional warrants. This session will feature experts discussing how Canadian players can leverage their current scale and position themselves to eventually dominate the American market, or whether the U.S.’s corporate muscle will overtake Canada’s progress to date.
10:30am - 11:00am

Networking Break

Europe represents a high growth but fragmented market, with disparate laws around medical cannabis across the European bloc. As more countries formally implement access pathways for patients, businesses must navigate Europe’s highly regulated healthcare space, capitalizing on commonalities to scale while remaining cognizant of country-to-country nuances. The protectionist outlook of many countries coupled with a typical preference towards pharmacy distribution are but two dynamics of which to be thoughtful. This session will analyze numerous market entry strategies, including sharing lessons learned from those who’ve already established a footprint across the region.
12:00pm - 1:30pm

Lunch

This year’s introduction of new product classes represents a second market launch, the evolution from an industry focused on plant matter to that of one centred around processed consumer goods. Panelists will examine how licensees are planning for new operational infrastructure, establishing research & development capabilities, and devising incisive go-to-market strategies. This will include the dichotomous balance between amassing the institutional knowledge internally and relying on the expertise of strategic partners, such as food and beverage manufacturers.
Despite the spotlight’s focus on legalization of adult-use access, Canada’s patient registrations have continued to increase since October 17. The heightened appreciation of the plant’s therapeutic potential has unlocked capital to uncover medical insights, such as bioavailability-optimized delivery mechanisms, applications of lesser known cannabinoids and the best practices in titration. This session will dissect the most significant research happening in Canada today and its commercial ramifications, including a sharpened understanding of cannabis as a medicine worldwide.
3:00pm - 3:30pm

Networking Break

Join us for a Fireside Chat between Mark Zekulin, President & Co-CEO of Canopy Growth Corporation and the Financial Post’s Vanmala Subramaniam. During this exclusive on-stage interview, Zekulin and Subramaniam will discuss themes that have permeated the entire day, and cover topics impacting Canada’s largest licensed producers including Canopy Growth Corporation (TSX: WEED) (NYSE:CGC).
Provincial oversight of cannabis retail has resulted in a patchwork of different regional approaches. In this critical look at the future of Canadian cannabis retail, we’ll hear from leaders of national brands on the pros and cons of taking a broad or niche approach and how to stay agile amid regulation rollouts, taxation and customer preferences. As new product categories become available, learn about how cross-sector integration can accelerate the success of edibles, beverages, concentrates and topicals. In addition, we examine what best-practices the industry can adopt from alcohol and other sectors.
5:00pm - 7:00pm

Networking Reception

Dragonfly Earth Medicine

Josh Sarvis and Kelly Dunn

Jones Brown

Alfredo Pascual

International Cannabis Consultant

Terry Lake

Vice-President of Corporate Social Responsibility at Hydropothecary

Aird & Berlis

David Hyde and Associates

Theo Tekstra

Vangst

Andrea Dobbs

Co-Founder, The Village Bloomery

Jan 12

08:00am - 09:00am

Registration & Breakfast

09:00am - 09:10am

Welcome Remarks

Welcome from LCBC Chair and Lift & Co. Board Member Deborah Rosati
Cannabis is poised to become one of the most influential consumer packaged goods industries in the world, and Canadian companies have a unique opportunity to build globally powerful brands. In a highly restricted marketing environment, data intelligence is paramount to understanding the customer and develop successful go-to-market strategies, as well as to build a passionate, knowledgeable and loyal consumer base. Lift & Co. and Headset take the stage to share combined insights into cannabis purchase and demographic analytics, discuss if Canada will follow U.S. trends and to provide an outlook on the future of the Canadian market.
As the United States inches towards an eventual lifting of its federal prohibition on cannabis, Canadian operators recognize the importance of penetrating the world’s largest economy. Cannabis’ continued Schedule I status and the U.S.’s notoriously competitive business philosophy make this a challenge: despite these factors, federally legal hemp offers one entry avenue, as do creative deals premised by conditional warrants. This session will feature experts discussing how Canadian players can leverage their current scale and position themselves to eventually dominate the American market, or whether the U.S.’s corporate muscle will overtake Canada’s progress to date.
10:30am - 11:00am

Networking Break

Europe represents a high growth but fragmented market, with disparate laws around medical cannabis across the European bloc. As more countries formally implement access pathways for patients, businesses must navigate Europe’s highly regulated healthcare space, capitalizing on commonalities to scale while remaining cognizant of country-to-country nuances. The protectionist outlook of many countries coupled with a typical preference towards pharmacy distribution are but two dynamics of which to be thoughtful. This session will analyze numerous market entry strategies, including sharing lessons learned from those who’ve already established a footprint across the region.
12:00pm - 1:30pm

Lunch

This year’s introduction of new product classes represents a second market launch, the evolution from an industry focused on plant matter to that of one centred around processed consumer goods. Panelists will examine how licensees are planning for new operational infrastructure, establishing research & development capabilities, and devising incisive go-to-market strategies. This will include the dichotomous balance between amassing the institutional knowledge internally and relying on the expertise of strategic partners, such as food and beverage manufacturers.
Despite the spotlight’s focus on legalization of adult-use access, Canada’s patient registrations have continued to increase since October 17. The heightened appreciation of the plant’s therapeutic potential has unlocked capital to uncover medical insights, such as bioavailability-optimized delivery mechanisms, applications of lesser known cannabinoids and the best practices in titration. This session will dissect the most significant research happening in Canada today and its commercial ramifications, including a sharpened understanding of cannabis as a medicine worldwide.
3:00pm - 3:30pm

Networking Break

Join us for a Fireside Chat between Mark Zekulin, President & Co-CEO of Canopy Growth Corporation and the Financial Post’s Vanmala Subramaniam. During this exclusive on-stage interview, Zekulin and Subramaniam will discuss themes that have permeated the entire day, and cover topics impacting Canada’s largest licensed producers including Canopy Growth Corporation (TSX: WEED) (NYSE:CGC).
Provincial oversight of cannabis retail has resulted in a patchwork of different regional approaches. In this critical look at the future of Canadian cannabis retail, we’ll hear from leaders of national brands on the pros and cons of taking a broad or niche approach and how to stay agile amid regulation rollouts, taxation and customer preferences. As new product categories become available, learn about how cross-sector integration can accelerate the success of edibles, beverages, concentrates and topicals. In addition, we examine what best-practices the industry can adopt from alcohol and other sectors.
5:00pm - 7:00pm

Networking Reception

Dragonfly Earth Medicine

Josh Sarvis and Kelly Dunn

Jones Brown

Alfredo Pascual

International Cannabis Consultant

Terry Lake

Vice-President of Corporate Social Responsibility at Hydropothecary

Aird & Berlis

David Hyde and Associates

Theo Tekstra

Vangst

Andrea Dobbs

Co-Founder, The Village Bloomery

Jan 13

08:00am - 09:00am

Registration & Breakfast

09:00am - 09:10am

Welcome Remarks

Welcome from LCBC Chair and Lift & Co. Board Member Deborah Rosati
Cannabis is poised to become one of the most influential consumer packaged goods industries in the world, and Canadian companies have a unique opportunity to build globally powerful brands. In a highly restricted marketing environment, data intelligence is paramount to understanding the customer and develop successful go-to-market strategies, as well as to build a passionate, knowledgeable and loyal consumer base. Lift & Co. and Headset take the stage to share combined insights into cannabis purchase and demographic analytics, discuss if Canada will follow U.S. trends and to provide an outlook on the future of the Canadian market.
As the United States inches towards an eventual lifting of its federal prohibition on cannabis, Canadian operators recognize the importance of penetrating the world’s largest economy. Cannabis’ continued Schedule I status and the U.S.’s notoriously competitive business philosophy make this a challenge: despite these factors, federally legal hemp offers one entry avenue, as do creative deals premised by conditional warrants. This session will feature experts discussing how Canadian players can leverage their current scale and position themselves to eventually dominate the American market, or whether the U.S.’s corporate muscle will overtake Canada’s progress to date.
10:30am - 11:00am

Networking Break

Europe represents a high growth but fragmented market, with disparate laws around medical cannabis across the European bloc. As more countries formally implement access pathways for patients, businesses must navigate Europe’s highly regulated healthcare space, capitalizing on commonalities to scale while remaining cognizant of country-to-country nuances. The protectionist outlook of many countries coupled with a typical preference towards pharmacy distribution are but two dynamics of which to be thoughtful. This session will analyze numerous market entry strategies, including sharing lessons learned from those who’ve already established a footprint across the region.
12:00pm - 1:30pm

Lunch

This year’s introduction of new product classes represents a second market launch, the evolution from an industry focused on plant matter to that of one centred around processed consumer goods. Panelists will examine how licensees are planning for new operational infrastructure, establishing research & development capabilities, and devising incisive go-to-market strategies. This will include the dichotomous balance between amassing the institutional knowledge internally and relying on the expertise of strategic partners, such as food and beverage manufacturers.
Despite the spotlight’s focus on legalization of adult-use access, Canada’s patient registrations have continued to increase since October 17. The heightened appreciation of the plant’s therapeutic potential has unlocked capital to uncover medical insights, such as bioavailability-optimized delivery mechanisms, applications of lesser known cannabinoids and the best practices in titration. This session will dissect the most significant research happening in Canada today and its commercial ramifications, including a sharpened understanding of cannabis as a medicine worldwide.
3:00pm - 3:30pm

Networking Break

Join us for a Fireside Chat between Mark Zekulin, President & Co-CEO of Canopy Growth Corporation and the Financial Post’s Vanmala Subramaniam. During this exclusive on-stage interview, Zekulin and Subramaniam will discuss themes that have permeated the entire day, and cover topics impacting Canada’s largest licensed producers including Canopy Growth Corporation (TSX: WEED) (NYSE:CGC).
Provincial oversight of cannabis retail has resulted in a patchwork of different regional approaches. In this critical look at the future of Canadian cannabis retail, we’ll hear from leaders of national brands on the pros and cons of taking a broad or niche approach and how to stay agile amid regulation rollouts, taxation and customer preferences. As new product categories become available, learn about how cross-sector integration can accelerate the success of edibles, beverages, concentrates and topicals. In addition, we examine what best-practices the industry can adopt from alcohol and other sectors.
5:00pm - 7:00pm

Networking Reception

Dragonfly Earth Medicine

Josh Sarvis and Kelly Dunn

Jones Brown

Alfredo Pascual

International Cannabis Consultant

Terry Lake

Vice-President of Corporate Social Responsibility at Hydropothecary

Aird & Berlis

David Hyde and Associates

Theo Tekstra

Vangst

Andrea Dobbs

Co-Founder, The Village Bloomery